Sanofi is requesting a Dengvaxia label change that will likely lead to fewer eligible recipients.

Pfizer's Prevnar 13 is set for another price hike in 2018, according to Kaiser Health News.

Here is some other vaccine news of note for the week.

With financial support from BARDA, Takeda's purified, inactivated, alum-adjuvanted Zika vaccine has entered human testing.

Here is some other vaccine news of note for the week.

Despite a frantic effort to rush Ebola vaccines through testing during an epidemic, Merck will fall short in its goal to file its candidate this year.

As Emergent BioSolutions pushes toward its goal of reaching $1 billion in annual revenues, the company has secured an important regulatory milestone.

Immunovaccine and Leidos are working together to determine the most promising malaria vaccine formulations.